Researchers are still working to answer key questions about the drug, including how effective it is in vaccinated people and whether cases of “rebounding” in people who receive it are common.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.